Objective Response Rate baseline to measured progressive disease, every three weeks [clinicaltrials_resource:73df4fea553efd3e094e1ba08edc5eda]

Objective Response Rate baseline to measured progressive disease, every three weeks [clinicaltrials_resource:73df4fea553efd3e094e1ba08edc5eda]

WHO criteria
clinicaltrials resource [clinicaltrials_vocabulary:Resource]
Primary outcome [clinicaltrials_vocabulary:primary-outcome]
http://bio2rdf.org/clinicaltrials_resource:73df4fea553efd3e094e1ba08edc5eda
Endostar and/or Cisplatin for Treatment of Malignant Pleural Effusion or Ascites [clinicaltrials:NCT01327235]
clinicaltrials_vocabulary:primary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:primary-outcome]

Objective Response Rate baseline to measured progressive disease, every three weeks [clinicaltrials_resource:73df4fea553efd3e094e1ba08edc5eda]

WHO criteria
clinicaltrials resource [clinicaltrials_vocabulary:Resource]
Primary outcome [clinicaltrials_vocabulary:primary-outcome]
http://bio2rdf.org/clinicaltrials_resource:73df4fea553efd3e094e1ba08edc5eda
Bio2RDF identifier
73df4fea553efd3e094e1ba08edc5eda
Bio2RDF namespace
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:73df4fea553efd3e094e1ba08edc5eda
measure [clinicaltrials_vocabulary:measure]
time frame [clinicaltrials_vocabulary:time-frame]
baseline to measured progressive disease, every three weeks
description
identifier
clinicaltrials_resource:73df4fea553efd3e094e1ba08edc5eda
title
Objective Response Rate baseline to measured progressive disease, every three weeks
@en
inDataset
type
label
Objective Response Rate baseli ...... f4fea553efd3e094e1ba08edc5eda]
@en